Author:
Yan Ying,Zhu Li,Zeng Miao,Huang Zhijian,Ding Qin,Liu Yang,Gao Chengyuan,Yu Doudou,Chen Xiao
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Ophthalmology,General Medicine
Reference31 articles.
1. Burden of illness of diabetic macular edema: literature review;Chen;Curr Med Res Opin,2010
2. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study;Massin;Diabetes Care,2010
3. Ranibizumab 0.5 mg for diabetic macular edema with bimonthly monitoring after a phase of initial treatment: 18-month, multicenter, phase IIIBRELIGHT study;Pearce;Ophthalmology,2015
4. Intravitreal aflibercept for diabetic macular edema;Jean-Fran Ois;Ophthalmology,2016
5. Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE;Brown;Ophthalmology,2013